---
$id: https://graph.org.ai/products/commodity/51181617
$type: Product
source: UNSPSC
code: "51181617"
title: "Methylthiouracil"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methylthiouracil

**UNSPSC Code**: 51181617
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antithyroid agent with the molecular formula C5H6N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QW24888U5F, chemically known as 2,3-dihydro-6-methyl-2-thioxo-4(1h)-pyrimidinone but generally known as methylthiouracil, which bears US NIH Compound Identifier 667493. European Medicines Agency schedules Methylthiouracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08878MIG. The term METHYLTHIOURACIL is an International Non-Proprietary Name. World Health Organization schedules methylthiouracil in its Anatomical Therapeutic Chemical (ATC) Classification. METHYLTHIOURACIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methylthiouracil under HS 29335995 and SITC 51576. As of Q4 2014, METHYLTHIOURACIL remains the US FDA Preferred Term for this commodity. Methylthiouracil bears US NLM identifiers UMLS ID C0025830 and NCI Concept Code C81590. SMILES: S=C1[NH]C(CC(=O)[NH]1)C.

